Dr. Dahlia Sano, MD

Dr. Sano practices at University Hospital in Ann Arbor, Michigan.

Dr. Sano's NPI, 1659631729, was assigned on May 23, 2012. Dr. Sano holds Michigan license 4301101024.

Dr. Sano's primary practice is University Hospital, at 1500 E Medical Center Dr, Ann Arbor, MI 48109. The practice phone is (734) 936-4000.

Dr. Sano's primary practice is University Hospital in Ann Arbor, Michigan. Dr. Sano is also affiliated with University Hospital. The medical group on file is University of Michigan Health. Dmand AI also links Dr. Sano to 2 more hospitals and 1 medical group, each named with a free account. Dr. Sano's employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sano practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sano's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Sano is licensed in Michigan.

CMS data shows 154 Medicare services from Dr. Sano across 6 procedure codes in 2024, for 99 Medicare patients. Medicare paid $14,119 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 99 Medicare patients who saw Dr. Sano in 2024. The largest group is 65 to 74, with 45 patients. 67% of them have high blood pressure, and 57% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sano's median patient age at 67, with 44% women.

In 2024, Dr. Sano wrote 316 Medicare Part D claims for 61 patients. 82% of them were for generic drugs. CMS names the drug for 250 of them, across 8 drugs with 11 or more claims each, at $420,481 in total drug cost. In 2023, CMS named 205 claims across 5 drugs.

Dr. Sano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sano as offering telehealth.

Dmand AI links 10 papers to Dr. Sano, published from 2017 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Antineoplastic Agents, Immunological. Dr. Sano's most frequent co-authors are Ali Faisal Ali Al Sbihi, MD, Ayad M. Al-Katib, MD and Tarik Hikmat Hadid, MD.

Dmand AI links Dr. Sano to 10 clinical trials, 5 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Hodgkin Disease, Lymphoma and Lymphoma, B-Cell. Barbara Ann Karmanos Cancer Institute sponsors the most, 3.

CMS Open Payments shows 48 general payments to Dr. Sano from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 40% of the total. Seagen Inc. paid the most, $1,620. It also lists 4 research payments totaling $3,915 from 2022 to 2025.